Evidence map›Paper›PMID 33317539›Full record

ArticleBMC biology2020

Analysis of urinary exosomal metabolites identifies cardiovascular risk signatures with added value to urine analysis.

Marta Agudiez, Paula J Martinez, Marta Martin-Lorenzo, Angeles Heredero, Aranzazu Santiago-Hernandez, Dolores Molero, Juan Manuel Garcia-Segura, Gonzalo Aldamiz-Echevarria, Gloria Alvarez-Llamas

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marta AgudiezImmunology Department, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain.
Paula J MartinezImmunology Department, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain.
Marta Martin-LorenzoImmunology Department, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain. marta.martin@fjd.es.
Angeles HerederoCardiac Surgery Department, Fundacion Jimenez Diaz-UAM, Madrid, Spain.
Aranzazu Santiago-HernandezImmunology Department, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain.
Dolores MoleroCAI-RMN, Universidad Complutense, Madrid, Spain.
Juan Manuel Garcia-SeguraCAI-RMN, Universidad Complutense, Madrid, Spain.
Gonzalo Aldamiz-EchevarriaCardiac Surgery Department, Fundacion Jimenez Diaz-UAM, Madrid, Spain.
Gloria Alvarez-LlamasImmunology Department, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain. galvarez@fjd.es.ORCID 0000-0002-3313-721X
Hospital Universitario Fundación Jiménez Díaz · ESUniversidad Complutense de Madrid · ESSpanish Clinical Research Network · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubclinical atherosclerosis may result in fatal cardiovascular (CV) events, but the underlying mechanisms and molecular players leading to disease are not entirely understood. Thus, novel approaches capable of identifying the factors involved in pathological progression and providing a better understanding of the subjacent mechanisms are needed. Extracellular vesicles (EVs) have been shown to have numerous biological functions, and their metabolome has recently generated interest as a source of novel biomarkers. The metabolic content of the exosomes has been so far unexplored in cardiovascular disease (CVD), and here, we developed an analytical strategy aimed at probing urinary exosomal metabolite content and its association to CV risk.

resultsDirect analysis of the exosomes without metabolite extraction was evaluated by high-resolution magic angle spinning (

conclusionsWe set up a novel methodology to analyze metabolic alterations in urinary exosomes and identified a cardiometabolic signature in these microvesicles. This study constitutes the first evidence of a role for the exosomal metabolism in CVD and demonstrates the possibility to evaluate the urinary exosomal metabolic content by NMR and MS.

Indexed as

AdultAgedCardiovascular DiseasesExosomesFemaleHumansMaleMiddle AgedRisk FactorsUrinalysisUrineBiomarkersCardiovascular riskExosomesMetabolitesNMRUrine

Identifiers

PMID33317539
PMCPMC7737341
OpenAlexW3111175310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.